← SEC 公告列表 | COO SEC 公告 | 庫珀醫療(COO)

季報 季度報告 10-Q 2026-06-05

Cooper Companies 提交截至4月底第二季度10-Q季報,披露完整財務數據與風險更新

於 SEC 網站開啟原文

AI 繁中摘要

Cooper Companies, Inc.(NYSE: COO)於2026年6月5日向美國證監會提交了截至2026年4月30日的季度報告(10-Q),涵蓋2026財年第二季度業績。📄 作為全球眼科醫療器材龍頭(主要產品包括隱形眼鏡及視力保健相關產品),今次申報文件包含了完整的未經審計財務報表、管理層討論與分析(MD&A)以及風險因素更新。雖然報告未有即時在標題摘要中列出具體收入或盈利數字,但按慣例,10-Q會詳細披露季度營收、毛利率、營運開支、淨利潤及每股盈利等關鍵指標,並對比去年同期及上一季度表現。🔍 管理層展望部分通常會就市場需求、供應鏈狀況、產品開發進度及外匯波動影響提供前瞻性指引。對於投資者而言,這份文件是評估公司短期財務健康狀況及未來增長動力的重要參考。💡 特別注意:由於10-Q屬季度強制披露,投資者應仔細閱讀其中關於流動性、現金流量及債務條款的變化,以及任何可能影響未來盈利能力的重大事項(如訴訟、監管變動或產品召回)。本報告亦附有XBRL互動數據,方便量化分析。 總部位於加州聖拉蒙的Cooper Companies,財政年度結束日為10月31日。完整文件已可於SEC EDGAR系統查閱(收件編號0001628280-26-041305)。
展開英文正文
EDGAR Filing Documents for 0001628280-26-041305

 
 
 
 
 
 
 

 
 
 SEC.gov
 
 

 
 EDGAR
 

 

 
 
 Latest Filings 
 

 
 Filings search tools
 

 
 
 Filing Detail

 
 SEC Home »

 Company Search »

 Current Page

 

 
 
 Form 10-Q - Quarterly report [Sections 13 or 15(d)]: 
 

 
 SEC Accession No. 0001628280-26-041305
 

 

 
 
 
 Filing Date

 2026-06-05

 Accepted

 2026-06-05 16:47:10

 Documents

 76

 

 
 Period of Report

 2026-04-30

 

 

 
  Interactive Data
 

 

 

 
 Document Format Files

 
 
 Seq
 Description
 Document
 Type
 Size
 

 
 1
 10-Q
 coo-20260430.htm   iXBRL
 10-Q
 1222874
 

 
 2
 EX-31.1
 coo-ex311_2026x04x30x10q.htm
 EX-31.1
 10322
 

 
 3
 EX-31.2
 coo-ex312_2026x04x30x10q.htm
 EX-31.2
 10403
 

 
 4
 EX-32.1
 coo-ex321_2026x04x30x10q.htm
 EX-32.1
 4540
 

 
 5
 EX-32.2
 coo-ex322_2026x04x30x10q.htm
 EX-32.2
 4534
 

 
 11
 GRAPHIC
 coo-20260430_g1.jpg
 GRAPHIC
 31412
 

 
 12
 GRAPHIC
 coo-20260430_g10.jpg
 GRAPHIC
 26122
 

 
 13
 GRAPHIC
 coo-20260430_g2.jpg
 GRAPHIC
 32650
 

 
 14
 GRAPHIC
 coo-20260430_g3.jpg
 GRAPHIC
 25660
 

 
 15
 GRAPHIC
 coo-20260430_g4.jpg
 GRAPHIC
 25335
 

 
 16
 GRAPHIC
 coo-20260430_g5.jpg
 GRAPHIC
 26571
 

 
 17
 GRAPHIC
 coo-20260430_g6.jpg
 GRAPHIC
 26291
 

 
 18
 GRAPHIC
 coo-20260430_g7.jpg
 GRAPHIC
 25010
 

 
 19
 GRAPHIC
 coo-20260430_g8.jpg
 GRAPHIC
 24826
 

 
 20
 GRAPHIC
 coo-20260430_g9.jpg
 GRAPHIC
 26106
 

 
  
 Complete submission text file
 0001628280-26-041305.txt
  
 7157088
 

 
 

 
 Data Files

 
 
 Seq
 Description
 Document
 Type
 Size
 

 
 6
 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
 coo-20260430.xsd
 EX-101.SCH
 33925
 

 
 7
 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
 coo-20260430_cal.xml
 EX-101.CAL
 63238
 

 
 8
 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
 coo-20260430_def.xml
 EX-101.DEF
 154996
 

 
 9
 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
 coo-20260430_lab.xml
 EX-101.LAB
 515555
 

 
 10
 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
 coo-20260430_pre.xml
 EX-101.PRE
 357459
 

 
 80
 EXTRACTED XBRL INSTANCE DOCUMENT
 coo-20260430_htm.xml
 XML
 1020855
 

 
 

 Mailing Address
 6101 BOLLINGER CANYON ROAD
 SUITE 500
 
SAN RAMON CA
94583 
 

 Business Address
 6101 BOLLINGER CANYON ROAD
 SUITE 500
 
SAN RAMON CA
94583 
 9254603600
 

 COOPER COMPANIES, INC. (Filer)
 CIK: 0000711404 (see all company filings)
EIN.: 942657368 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-08597 | Film No.: 261069927
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)